nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Hypertrophy—Brimonidine—glaucoma	0.133	0.164	CcSEcCtD
Nandrolone decanoate—Hirsutism—Bimatoprost—glaucoma	0.0244	0.0301	CcSEcCtD
Nandrolone decanoate—Local reaction—Dorzolamide—glaucoma	0.0217	0.0267	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Pilocarpine—glaucoma	0.0167	0.0205	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Latanoprost—glaucoma	0.0152	0.0187	CcSEcCtD
Nandrolone decanoate—Hypertension—Dipivefrin—glaucoma	0.0152	0.0187	CcSEcCtD
Nandrolone decanoate—Acne—Brimonidine—glaucoma	0.0149	0.0184	CcSEcCtD
Nandrolone decanoate—Dysphonia—Travoprost—glaucoma	0.0145	0.0179	CcSEcCtD
Nandrolone decanoate—Libido decreased—Apraclonidine—glaucoma	0.0115	0.0141	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Levobunolol—glaucoma	0.0114	0.0141	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Betaxolol—glaucoma	0.0109	0.0135	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Acetazolamide—glaucoma	0.0109	0.0134	CcSEcCtD
Nandrolone decanoate—MAOB—Dopamine metabolism—SOD1—glaucoma	0.0107	0.0589	CbGpPWpGaD
Nandrolone decanoate—Disturbance in sexual arousal—Apraclonidine—glaucoma	0.0106	0.013	CcSEcCtD
Nandrolone decanoate—Irritability—Apraclonidine—glaucoma	0.0102	0.0125	CcSEcCtD
Nandrolone decanoate—Nausea—Physostigmine—glaucoma	0.01	0.0123	CcSEcCtD
Nandrolone decanoate—Libido decreased—Dorzolamide—glaucoma	0.0094	0.0116	CcSEcCtD
Nandrolone decanoate—Libido decreased—Brinzolamide—glaucoma	0.00924	0.0114	CcSEcCtD
Nandrolone decanoate—Irritability—Acetazolamide—glaucoma	0.00908	0.0112	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—PITX2—glaucoma	0.00876	0.0481	CbGpPWpGaD
Nandrolone decanoate—Disturbance in sexual arousal—Dorzolamide—glaucoma	0.00865	0.0106	CcSEcCtD
Nandrolone decanoate—Hypertension—Metipranolol—glaucoma	0.00852	0.0105	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Brinzolamide—glaucoma	0.0085	0.0105	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Latanoprost—glaucoma	0.00829	0.0102	CcSEcCtD
Nandrolone decanoate—Irritability—Brinzolamide—glaucoma	0.00818	0.0101	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Clonidine—glaucoma	0.00811	0.00998	CcSEcCtD
Nandrolone decanoate—Oedema—Metipranolol—glaucoma	0.00805	0.00991	CcSEcCtD
Nandrolone decanoate—Oedema—Carteolol—glaucoma	0.00746	0.00918	CcSEcCtD
Nandrolone decanoate—Libido decreased—Clonidine—glaucoma	0.0071	0.00873	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Dorzolamide—glaucoma	0.00694	0.00854	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Brinzolamide—glaucoma	0.00682	0.0084	CcSEcCtD
Nandrolone decanoate—MAOA—Dopamine metabolism—SOD1—glaucoma	0.00674	0.037	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Apraclonidine—glaucoma	0.00663	0.00816	CcSEcCtD
Nandrolone decanoate—Oedema—Latanoprost—glaucoma	0.00654	0.00805	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Clonidine—glaucoma	0.00653	0.00803	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Bimatoprost—glaucoma	0.00643	0.00791	CcSEcCtD
Nandrolone decanoate—Irritability—Clonidine—glaucoma	0.00628	0.00773	CcSEcCtD
Nandrolone decanoate—Libido decreased—Betaxolol—glaucoma	0.00618	0.0076	CcSEcCtD
Nandrolone decanoate—MAOA—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00583	0.032	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Brimonidine—glaucoma	0.00569	0.00701	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Betaxolol—glaucoma	0.00568	0.00699	CcSEcCtD
Nandrolone decanoate—Urticaria—Levobunolol—glaucoma	0.0056	0.00689	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Travoprost—glaucoma	0.00541	0.00666	CcSEcCtD
Nandrolone decanoate—Urticaria—Methazolamide—glaucoma	0.00537	0.0066	CcSEcCtD
Nandrolone decanoate—Hypertension—Bimatoprost—glaucoma	0.00536	0.0066	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Brinzolamide—glaucoma	0.00534	0.00658	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Clonidine—glaucoma	0.00524	0.00645	CcSEcCtD
Nandrolone decanoate—Oedema—Apraclonidine—glaucoma	0.00523	0.00643	CcSEcCtD
Nandrolone decanoate—Pruritus—Diclofenamide—glaucoma	0.00519	0.00639	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00513	0.0282	CbGpPWpGaD
Nandrolone decanoate—Rash—Metipranolol—glaucoma	0.00508	0.00625	CcSEcCtD
Nandrolone decanoate—Dermatitis—Metipranolol—glaucoma	0.00507	0.00624	CcSEcCtD
Nandrolone decanoate—Libido decreased—Timolol—glaucoma	0.00505	0.00621	CcSEcCtD
Nandrolone decanoate—Pruritus—Levobunolol—glaucoma	0.00499	0.00614	CcSEcCtD
Nandrolone decanoate—Nausea—Metipranolol—glaucoma	0.00478	0.00589	CcSEcCtD
Nandrolone decanoate—Hypertension—Brimonidine—glaucoma	0.00475	0.00584	CcSEcCtD
Nandrolone decanoate—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.00467	0.0256	CbGpPWpGaD
Nandrolone decanoate—Disturbance in sexual arousal—Timolol—glaucoma	0.00464	0.00571	CcSEcCtD
Nandrolone decanoate—Pruritus—Latanoprost—glaucoma	0.00463	0.00569	CcSEcCtD
Nandrolone decanoate—Rash—Diclofenamide—glaucoma	0.00463	0.00569	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Betaxolol—glaucoma	0.00456	0.00561	CcSEcCtD
Nandrolone decanoate—Hypertension—Dorzolamide—glaucoma	0.00453	0.00558	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00453	0.0249	CbGpPWpGaD
Nandrolone decanoate—Rash—Carbachol—glaucoma	0.00451	0.00556	CcSEcCtD
Nandrolone decanoate—Hypertension—Travoprost—glaucoma	0.00451	0.00556	CcSEcCtD
Nandrolone decanoate—Dermatitis—Carbachol—glaucoma	0.00451	0.00555	CcSEcCtD
Nandrolone decanoate—Oedema—Brimonidine—glaucoma	0.00449	0.00552	CcSEcCtD
Nandrolone decanoate—Hypertension—Brinzolamide—glaucoma	0.00446	0.00549	CcSEcCtD
Nandrolone decanoate—Nausea—Carteolol—glaucoma	0.00443	0.00546	CcSEcCtD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP1B1—glaucoma	0.00438	0.0241	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00436	0.024	CbGpPWpGaD
Nandrolone decanoate—Nausea—Diclofenamide—glaucoma	0.00436	0.00536	CcSEcCtD
Nandrolone decanoate—Oedema—Dorzolamide—glaucoma	0.00429	0.00527	CcSEcCtD
Nandrolone decanoate—Hypertension—Pilocarpine—glaucoma	0.00428	0.00527	CcSEcCtD
Nandrolone decanoate—Oedema—Travoprost—glaucoma	0.00427	0.00525	CcSEcCtD
Nandrolone decanoate—MAOA—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.00427	0.0234	CbGpPWpGaD
Nandrolone decanoate—Rash—Methazolamide—glaucoma	0.00426	0.00524	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methazolamide—glaucoma	0.00425	0.00524	CcSEcCtD
Nandrolone decanoate—Nausea—Carbachol—glaucoma	0.00425	0.00523	CcSEcCtD
Nandrolone decanoate—Nausea—Levobunolol—glaucoma	0.00419	0.00515	CcSEcCtD
Nandrolone decanoate—Rash—Latanoprost—glaucoma	0.00412	0.00507	CcSEcCtD
Nandrolone decanoate—Dermatitis—Latanoprost—glaucoma	0.00412	0.00507	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Clonidine—glaucoma	0.0041	0.00505	CcSEcCtD
Nandrolone decanoate—Oedema—Pilocarpine—glaucoma	0.00405	0.00498	CcSEcCtD
Nandrolone decanoate—Nausea—Methazolamide—glaucoma	0.00401	0.00494	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00398	0.0218	CbGpPWpGaD
Nandrolone decanoate—Erectile dysfunction—Timolol—glaucoma	0.00373	0.00458	CcSEcCtD
Nandrolone decanoate—Urticaria—Acetazolamide—glaucoma	0.00371	0.00457	CcSEcCtD
Nandrolone decanoate—Pruritus—Apraclonidine—glaucoma	0.0037	0.00455	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—BAD—glaucoma	0.00368	0.0202	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Bimatoprost—glaucoma	0.00359	0.00441	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Betaxolol—glaucoma	0.00357	0.0044	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD1—glaucoma	0.00345	0.0189	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.00344	0.0189	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Dorzolamide—glaucoma	0.0034	0.00419	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.00337	0.0185	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Brinzolamide—glaucoma	0.00335	0.00412	CcSEcCtD
Nandrolone decanoate—Dermatitis—Apraclonidine—glaucoma	0.00329	0.00405	CcSEcCtD
Nandrolone decanoate—Oedema—Clonidine—glaucoma	0.00323	0.00398	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—EDN1—glaucoma	0.00322	0.0177	CbGpPWpGaD
Nandrolone decanoate—Rash—Bimatoprost—glaucoma	0.0032	0.00393	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bimatoprost—glaucoma	0.00319	0.00393	CcSEcCtD
Nandrolone decanoate—Pruritus—Brimonidine—glaucoma	0.00317	0.00391	CcSEcCtD
Nandrolone decanoate—Nausea—Apraclonidine—glaucoma	0.0031	0.00382	CcSEcCtD
Nandrolone decanoate—Pruritus—Dorzolamide—glaucoma	0.00303	0.00373	CcSEcCtD
Nandrolone decanoate—Pruritus—Travoprost—glaucoma	0.00302	0.00372	CcSEcCtD
Nandrolone decanoate—Nausea—Bimatoprost—glaucoma	0.00301	0.00371	CcSEcCtD
Nandrolone decanoate—Pruritus—Brinzolamide—glaucoma	0.00298	0.00367	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Timolol—glaucoma	0.00292	0.00359	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SOD1—glaucoma	0.00288	0.0158	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00287	0.0158	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Pilocarpine—glaucoma	0.00287	0.00353	CcSEcCtD
Nandrolone decanoate—Rash—Brimonidine—glaucoma	0.00283	0.00348	CcSEcCtD
Nandrolone decanoate—Dermatitis—Brimonidine—glaucoma	0.00283	0.00348	CcSEcCtD
Nandrolone decanoate—Oedema—Betaxolol—glaucoma	0.00282	0.00347	CcSEcCtD
Nandrolone decanoate—Nausea—Acetazolamide—glaucoma	0.00278	0.00342	CcSEcCtD
Nandrolone decanoate—Rash—Dorzolamide—glaucoma	0.0027	0.00333	CcSEcCtD
Nandrolone decanoate—Dermatitis—Dorzolamide—glaucoma	0.0027	0.00332	CcSEcCtD
Nandrolone decanoate—Rash—Travoprost—glaucoma	0.00269	0.00331	CcSEcCtD
Nandrolone decanoate—Dermatitis—Travoprost—glaucoma	0.00269	0.00331	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—NR3C1—glaucoma	0.00269	0.0147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.00268	0.0147	CbGpPWpGaD
Nandrolone decanoate—Nausea—Brimonidine—glaucoma	0.00267	0.00328	CcSEcCtD
Nandrolone decanoate—Rash—Brinzolamide—glaucoma	0.00266	0.00327	CcSEcCtD
Nandrolone decanoate—Dermatitis—Brinzolamide—glaucoma	0.00265	0.00327	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—APOE—glaucoma	0.00262	0.0144	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Clonidine—glaucoma	0.00257	0.00316	CcSEcCtD
Nandrolone decanoate—Rash—Pilocarpine—glaucoma	0.00255	0.00314	CcSEcCtD
Nandrolone decanoate—Dermatitis—Pilocarpine—glaucoma	0.00255	0.00314	CcSEcCtD
Nandrolone decanoate—Nausea—Dorzolamide—glaucoma	0.00255	0.00313	CcSEcCtD
Nandrolone decanoate—Nausea—Travoprost—glaucoma	0.00253	0.00312	CcSEcCtD
Nandrolone decanoate—Nausea—Brinzolamide—glaucoma	0.0025	0.00308	CcSEcCtD
Nandrolone decanoate—Hypertension—Timolol—glaucoma	0.00243	0.00299	CcSEcCtD
Nandrolone decanoate—Nausea—Pilocarpine—glaucoma	0.00241	0.00296	CcSEcCtD
Nandrolone decanoate—Oedema—Timolol—glaucoma	0.0023	0.00283	CcSEcCtD
Nandrolone decanoate—Pruritus—Clonidine—glaucoma	0.00229	0.00282	CcSEcCtD
Nandrolone decanoate—Urticaria—Betaxolol—glaucoma	0.00224	0.00275	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00217	0.0119	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00214	0.0117	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00212	0.0117	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP1B1—glaucoma	0.00211	0.394	CrCbGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.00206	0.0113	CbGpPWpGaD
Nandrolone decanoate—Rash—Clonidine—glaucoma	0.00204	0.00251	CcSEcCtD
Nandrolone decanoate—Dermatitis—Clonidine—glaucoma	0.00204	0.00251	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP1B1—glaucoma	0.002	0.372	CrCbGaD
Nandrolone decanoate—Pruritus—Betaxolol—glaucoma	0.00199	0.00245	CcSEcCtD
Nandrolone decanoate—Nausea—Clonidine—glaucoma	0.00192	0.00236	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTT1—glaucoma	0.00191	0.0105	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.00188	0.0103	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00184	0.0101	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Timolol—glaucoma	0.00183	0.00225	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.0018	0.00989	CbGpPWpGaD
Nandrolone decanoate—Rash—Betaxolol—glaucoma	0.00178	0.00218	CcSEcCtD
Nandrolone decanoate—Dermatitis—Betaxolol—glaucoma	0.00177	0.00218	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00176	0.00965	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00167	0.00918	CbGpPWpGaD
Nandrolone decanoate—Nausea—Betaxolol—glaucoma	0.00167	0.00206	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.00167	0.00917	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Timolol—glaucoma	0.00163	0.002	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00162	0.00891	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00153	0.0084	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP1B1—glaucoma	0.00153	0.00838	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00147	0.00805	CbGpPWpGaD
Nandrolone decanoate—Rash—Timolol—glaucoma	0.00145	0.00178	CcSEcCtD
Nandrolone decanoate—Dermatitis—Timolol—glaucoma	0.00145	0.00178	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.00138	0.00757	CbGpPWpGaD
Nandrolone decanoate—Nausea—Timolol—glaucoma	0.00137	0.00168	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—CA5A—glaucoma	0.00134	0.00737	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NARFL—glaucoma	0.00134	0.00737	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00132	0.00723	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.00131	0.00718	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—SLC6A13—glaucoma	0.00128	0.00704	CbGpPWpGaD
Nandrolone decanoate—Progesterone—NR3C1—glaucoma	0.00126	0.234	CrCbGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00122	0.00672	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00122	0.00672	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GSTM1—glaucoma	0.00122	0.0067	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTT1—glaucoma	0.0012	0.0066	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.0012	0.00658	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.0012	0.00658	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.00117	0.00643	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00116	0.00638	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.00105	0.00578	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000983	0.00539	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000965	0.0053	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP1B1—glaucoma	0.000957	0.00526	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000943	0.00518	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—SLC6A1—glaucoma	0.000938	0.00515	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000934	0.00513	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000921	0.00506	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000913	0.00501	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000872	0.00479	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000872	0.00479	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000868	0.00476	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000867	0.00476	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NARFL—glaucoma	0.000842	0.00462	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA5A—glaucoma	0.000842	0.00462	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000841	0.00462	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000836	0.00459	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000832	0.00457	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA5A—glaucoma	0.000821	0.00451	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NARFL—glaucoma	0.000821	0.00451	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000819	0.00449	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000791	0.00435	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	0.000769	0.00422	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000766	0.0042	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTM1—glaucoma	0.000765	0.0042	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000746	0.0041	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000738	0.00405	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000736	0.00404	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000715	0.00393	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000704	0.00387	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA1—glaucoma	0.000655	0.0036	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000635	0.00349	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CTSA—glaucoma	0.000635	0.00348	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000612	0.00336	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA2—glaucoma	0.000599	0.00329	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00045	0.00247	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000428	0.00235	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000426	0.00234	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TXN—glaucoma	0.000422	0.00232	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000418	0.00229	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000417	0.00229	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA1—glaucoma	0.000411	0.00226	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA1—glaucoma	0.000401	0.0022	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CTSA—glaucoma	0.000398	0.00219	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CTSA—glaucoma	0.000388	0.00213	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA2—glaucoma	0.000376	0.00206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000368	0.00202	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000367	0.00202	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA2—glaucoma	0.000367	0.00201	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR3C1—glaucoma	0.000367	0.00201	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000359	0.00197	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000359	0.00197	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—glaucoma	0.000357	0.00196	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000354	0.00194	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—glaucoma	0.000327	0.0018	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000323	0.00177	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	0.000315	0.00173	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000304	0.00167	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000278	0.00153	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000268	0.00147	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TXN—glaucoma	0.000265	0.00145	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1B1—glaucoma	0.000261	0.00143	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCA1—glaucoma	0.000261	0.00143	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TXN—glaucoma	0.000258	0.00142	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000236	0.00129	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000234	0.00128	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—glaucoma	0.000209	0.00115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—glaucoma	0.000205	0.00113	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CDKN2B—glaucoma	0.000201	0.0011	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—glaucoma	0.0002	0.0011	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—glaucoma	0.000184	0.00101	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR3C1—glaucoma	0.000177	0.000969	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APOE—glaucoma	0.000172	0.000942	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—glaucoma	0.00017	0.000933	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCA1—glaucoma	0.000164	0.000899	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1B1—glaucoma	0.000164	0.000899	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000162	0.000887	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1B1—glaucoma	0.00016	0.000877	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCA1—glaucoma	0.00016	0.000877	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—glaucoma	0.000131	0.000719	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NOS3—glaucoma	0.000129	0.000706	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—glaucoma	0.000128	0.000701	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—glaucoma	0.000118	0.000646	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—glaucoma	0.000116	0.000635	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—glaucoma	0.000113	0.000619	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APOE—glaucoma	0.000108	0.000591	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—glaucoma	0.000107	0.000586	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APOE—glaucoma	0.000105	0.000577	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—glaucoma	0.000104	0.000571	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NOS3—glaucoma	8.07e-05	0.000443	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NOS3—glaucoma	7.87e-05	0.000432	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—glaucoma	7.38e-05	0.000405	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—glaucoma	7.2e-05	0.000395	CbGpPWpGaD
